Replies to post #8861 on ProtoKinetix Inc (PKTX)

[gosox12]

Scoobey,

From the 4/6 PR:

"These positive results in efficacy and safety in the recent testing of our AAGP(R) for dry eye disease is extremely promising for the future of using our molecule to treat this disease." - said Clarence E. Smith, President and Chief Executive Officer of ProtoKinetix. "We are currently planning to move forward with the next stages of development ourselves."

Note the last sentence: "...move forward....ourselves"

So, it looks like they're not going to be partnering/licensing with a Big Pharma for this indication.